NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate

Gobin, B., Battaglia, S., Lanel, R. et al. (5 more authors) (2014) NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate. Cancer Letters, 344 (2). pp. 291-298. ISSN 0304-3835

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 Elsevier B.V. or its licensors or contributors.
Keywords: PI3K Inhibitor; mTOR Inhibitor; Survival rate; Pre-clinical model; Osteosarcoma
Dates:
  • Published: 28 March 2014
  • Published (online): 11 December 2013
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 06 May 2016 07:49
Last Modified: 06 Jun 2016 00:00
Published Version: http://dx.doi.org/10.1016/j.canlet.2013.11.017
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.canlet.2013.11.017
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics